PT1002792E - Compostos de 2-aminopropano-1,3-diol, sua utilizacao medicinal e intermediariosda sintese dos mesmos - Google Patents

Compostos de 2-aminopropano-1,3-diol, sua utilizacao medicinal e intermediariosda sintese dos mesmos

Info

Publication number
PT1002792E
PT1002792E PT98911211T PT98911211T PT1002792E PT 1002792 E PT1002792 E PT 1002792E PT 98911211 T PT98911211 T PT 98911211T PT 98911211 T PT98911211 T PT 98911211T PT 1002792 E PT1002792 E PT 1002792E
Authority
PT
Portugal
Prior art keywords
compound
same
diole
aminopropane
medicinal
Prior art date
Application number
PT98911211T
Other languages
English (en)
Inventor
Tetsuro Fujita
Kunitomo Adachi
Koji Teshima
Yoshiyuki Aoki
Tokushi Hanano
Yukio Hoshino
Original Assignee
Mitsubishi Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp
Publication of PT1002792E publication Critical patent/PT1002792E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/16—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound oxygen atoms bound to the same carbon atom of an acyclic carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C225/14—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
    • C07C225/16—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C07C215/34—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton and at least one hydroxy group bound to another carbon atom of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C223/00—Compounds containing amino and —CHO groups bound to the same carbon skeleton
    • C07C223/02—Compounds containing amino and —CHO groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
PT98911211T 1997-04-04 1998-04-03 Compostos de 2-aminopropano-1,3-diol, sua utilizacao medicinal e intermediariosda sintese dos mesmos PT1002792E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8625597 1997-04-04

Publications (1)

Publication Number Publication Date
PT1002792E true PT1002792E (pt) 2004-12-31

Family

ID=13881722

Family Applications (2)

Application Number Title Priority Date Filing Date
PT98911211T PT1002792E (pt) 1997-04-04 1998-04-03 Compostos de 2-aminopropano-1,3-diol, sua utilizacao medicinal e intermediariosda sintese dos mesmos
PT03003623T PT1319651E (pt) 1997-04-04 1998-04-03 Composto 2-aminopropano-1,3-diol, sua utilizacao farmaceutica e seus intermediarios sinteticos

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT03003623T PT1319651E (pt) 1997-04-04 1998-04-03 Composto 2-aminopropano-1,3-diol, sua utilizacao farmaceutica e seus intermediarios sinteticos

Country Status (18)

Country Link
US (2) USRE39072E1 (pt)
EP (2) EP1319651B1 (pt)
JP (1) JP4045364B2 (pt)
KR (1) KR100551931B1 (pt)
CN (2) CN1137086C (pt)
AT (2) ATE298740T1 (pt)
AU (1) AU735853B2 (pt)
BR (1) BR9808481A (pt)
CA (1) CA2286315C (pt)
DE (2) DE69825056T2 (pt)
DK (2) DK1002792T3 (pt)
ES (2) ES2240868T3 (pt)
IL (3) IL132208A (pt)
NZ (1) NZ500713A (pt)
PT (2) PT1002792E (pt)
RU (1) RU2198162C2 (pt)
SI (2) SI1002792T1 (pt)
WO (1) WO1998045249A1 (pt)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861442B1 (en) * 1998-12-30 2005-03-01 Sugen, Inc. PYK2 and inflammation
US6515117B2 (en) * 1999-10-12 2003-02-04 Bristol-Myers Squibb Company C-aryl glucoside SGLT2 inhibitors and method
WO2002006268A1 (fr) 2000-07-13 2002-01-24 Sankyo Company, Limited Derives d'alcool amino
AU2001296536A1 (en) 2000-10-03 2002-04-15 University Of Virginian Patent Foundation Novel lysophosphatidic acid receptor agonists and antagonists
US20040241211A9 (en) * 2000-11-06 2004-12-02 Fischell Robert E. Devices and methods for reducing scar tissue formation
US6534693B2 (en) * 2000-11-06 2003-03-18 Afmedica, Inc. Surgically implanted devices having reduced scar tissue formation
US7064217B2 (en) 2001-01-30 2006-06-20 University Of Virginia Patent Foundation Agonists and antagonists of sphingosine-1-phosphate receptors
WO2002067915A1 (en) * 2001-02-22 2002-09-06 Novartis Ag Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment of delayed graft function
US20030072717A1 (en) * 2001-02-23 2003-04-17 Vapotronics, Inc. Inhalation device having an optimized air flow path
CZ20032560A3 (cs) 2001-03-26 2003-12-17 Novartis Ag Deriváty 2-aminopropanolu, způsob jejich přípravy a farmaceutický prostředek, který je obsahuje
JP5342730B2 (ja) * 2001-05-21 2013-11-13 インジェット デジタル エアロソルズ リミテッド 経肺経路を介するタンパク質送達のための組成物
GB0117921D0 (en) * 2001-07-23 2001-09-12 Novartis Ag Organic compounds
WO2003029184A1 (fr) * 2001-09-27 2003-04-10 Kyorin Pharmaceutical Co., Ltd. Derive d'ether de diaryle, son sel d'addition et son immunosuppresseur
JP4217620B2 (ja) 2001-09-27 2009-02-04 杏林製薬株式会社 ジアリールスルフィド誘導体とその付加塩及び免疫抑制剤
GB0125443D0 (en) * 2001-10-23 2001-12-12 Novartis Ag Organic Compounds
AU2003202495B2 (en) * 2002-01-11 2006-07-20 Sankyo Company, Limited Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
US6797722B2 (en) * 2002-05-03 2004-09-28 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole for the treatment of autoimmune diseases
EP1944026B1 (en) 2002-05-16 2013-06-26 Novartis AG Use of EDG receptor binding agents in cancer
GB0217152D0 (en) * 2002-07-24 2002-09-04 Novartis Ag Organic compounds
CA2497067A1 (en) 2002-09-13 2004-03-25 Novartis Ag Amino-propanol derivatives
WO2004028521A2 (en) * 2002-09-24 2004-04-08 Novartis Ag Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders
AU2008200368B2 (en) * 2003-04-08 2011-04-28 Mitsubishi Tanabe Pharma Corporation Solid pharmaceutical compositions comprising a S1P receptor agonist and a sugar alcohol
MXPA05010860A (es) * 2003-04-08 2006-05-25 Novartis Ag Composiciones solidas farmaceuticas que comprenden un agonista de receptor sip y y un alcohol de azucar.
AU2011205050B2 (en) * 2003-04-08 2014-01-30 Mitsubishi Tanabe Pharma Corporation Solid pharmaceutical compositions comprising a S1P receptor agonist and a sugar alcohol
ATE547395T1 (de) * 2003-04-30 2012-03-15 Novartis Pharma Gmbh Aminopropanol-derivate als modulatoren des sphingosin-1-phosphat-rezeptors
MY150088A (en) 2003-05-19 2013-11-29 Irm Llc Immunosuppressant compounds and compositions
US7524887B2 (en) 2003-06-06 2009-04-28 Sanofi-Aventis Deutschland Gmbh 2-amino-1,3-propanediol compounds for the treatment of acute pain
EP1484057A1 (en) * 2003-06-06 2004-12-08 Aventis Pharma Deutschland GmbH Use of 2-amino-1-3-propanediol derivatives for the manufacture of a medicament for the treatment of various types of pain
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
GB0320638D0 (en) 2003-09-03 2003-10-01 Novartis Ag Organic compounds
GB0324210D0 (en) 2003-10-15 2003-11-19 Novartis Ag Organic compounds
GB0329498D0 (en) 2003-12-19 2004-01-28 Novartis Ag Organic compounds
GB0500020D0 (en) 2005-01-04 2005-02-09 Novartis Ag Organic compounds
TWI355934B (en) 2004-02-24 2012-01-11 Sankyo Co Pharmaceutical composition for treatment or prophy
JP2007536310A (ja) * 2004-05-03 2007-12-13 ノバルティス アクチエンゲゼルシャフト Ｓ１ｐ受容体アゴニストおよびｊａｋ３キナーゼ阻害剤を含む、組合せ剤
US7820703B2 (en) 2004-05-06 2010-10-26 University Of Virginia Patent Foundation Lysophosphatidic acid receptor selective antagonists
GB0411929D0 (en) * 2004-05-27 2004-06-30 Novartis Ag Organic compounds
CA2571710A1 (en) 2004-06-24 2006-11-02 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
ATE502630T1 (de) * 2004-07-16 2011-04-15 Kyorin Seiyaku Kk Verfahren zur effektiven anwendung eines medikaments und verfahren zur prävention von nebenwirkungen
JP4919374B2 (ja) * 2004-07-29 2012-04-18 第一三共株式会社 免疫抑制剤としての医薬組成物
TW200611687A (en) * 2004-07-29 2006-04-16 Sankyo Co Pharmaceutical compositions used for immunosuppressant
US20080096972A1 (en) 2004-07-30 2008-04-24 Thitiwan Buranachokpaisan Compound formulations of 2-amino-1, 3-propanediol compounds
US20060223866A1 (en) * 2004-08-13 2006-10-05 Praecis Pharmaceuticals, Inc. Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity
AU2005272619A1 (en) * 2004-08-13 2006-02-23 Praecis Pharmaceuticals, Inc. Methods and compositions for modulating sphingosine-1-phosphate (SIP) receptor activity
RU2376285C2 (ru) * 2004-10-12 2009-12-20 Киорин Фармасьютикал Ко., Лтд. Процесс получения гидрохлорида 2-амино-2-[2-[4-(3-бензилоксифенилтио)-2-хлорфенилэтил]-1,3-пропандиола] и его гидратов, а также промежуточные продукты их получения
WO2006058316A1 (en) 2004-11-29 2006-06-01 Novartis Ag Dosage regimen of an s1p receptor agonist
BRPI0607740A2 (pt) * 2005-02-08 2009-09-29 Novartis Ag indução de anticorpos antilinfócitos
GB0504544D0 (en) 2005-03-04 2005-04-13 Novartis Ag Organic compounds
TW200702326A (en) * 2005-05-31 2007-01-16 Mitsubishi Pharma Corp 2-aminobutanol compound and its pharmaceutical use
TWI418350B (zh) * 2005-06-24 2013-12-11 Sankyo Co 含有ｐｐａｒ調節劑之醫藥組成物的用途
GT200600350A (es) * 2005-08-09 2007-03-28 Formulaciones líquidas
RU2421214C2 (ru) * 2005-10-07 2011-06-20 Киорин Фармасьютикал Ко., Лтд. Терапевтическое средство для лечения гепатита и способ лечения гепатита
TWI389683B (zh) * 2006-02-06 2013-03-21 Kyorin Seiyaku Kk A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient
US7825152B2 (en) 2006-04-11 2010-11-02 Novartis Ag Organic compounds and their uses
GB0612721D0 (en) 2006-06-27 2006-08-09 Novartis Ag Organic compounds
TW200815600A (en) 2006-08-04 2008-04-01 Daiichi Sankyo Co Ltd An enzyme for phosphorizing a medicine
SG174029A1 (en) * 2006-08-08 2011-09-29 Kyorin Seiyaku Kk Aminoalcohol derivative and immunosuppressant containing the same as active ingredient
MY152176A (en) * 2006-08-08 2014-08-15 Kyorin Seiyaku Kk Amino phosphate derivative and s1p receptor modulator having same as an active ingredient
KR101884047B1 (ko) 2006-09-26 2018-07-31 노파르티스 아게 Ｓ１ｐ 조정제를 포함하는 제약 조성물
WO2008121709A1 (en) * 2007-03-30 2008-10-09 Transport Pharmaceuticals, Inc. Pharmaceutical formulations for iontophoretic delivery of an anti-fungal drug
MX2009013730A (es) 2007-06-14 2010-01-26 Mitsubishi Tanabe Pharma Corp Compuesto amina y uso farmaceutico del mismo.
DE102007039954A1 (de) * 2007-08-23 2009-02-26 Henkel Ag & Co. Kgaa Reduktive Entfärbung keratinhaltiger Fasern
PL2952177T3 (pl) 2007-10-12 2021-07-19 Novartis Ag Kompozycje zawierające modulatory receptora fosforanu sfingozyny 1 (s1p)
JP5452237B2 (ja) 2008-02-07 2014-03-26 杏林製薬株式会社 アミノアルコール誘導体を有効成分とする炎症性腸疾患の治療剤又は予防剤
US20110182850A1 (en) 2009-04-10 2011-07-28 Trixi Brandl Organic compounds and their uses
US8512690B2 (en) 2009-04-10 2013-08-20 Novartis Ag Derivatised proline containing peptide compounds as protease inhibitors
CA2811799A1 (en) 2010-10-08 2012-04-12 Novartis Ag Vitamin e formulations of sulfamide ns3 inhibitors
AR085749A1 (es) 2011-04-01 2013-10-23 Novartis Ag Formulaciones
EP2842937B1 (en) 2012-04-23 2018-01-17 Mitsubishi Tanabe Pharma Corporation Amine compound and use thereof for medical purposes
CN110862409B (zh) * 2019-12-04 2021-08-20 江南大学 一种制备含二元醇结构的硅烷类化合物及其改性水性聚氨酯的方法
US20220153684A1 (en) * 2020-11-13 2022-05-19 Shivalik Rasayan Limited Process for preparation of fingolimod hydrochloride

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3660488A (en) 1965-07-16 1972-05-02 Phillips Petroleum Co 2-halo-alkylene- and -cyclopentylene-2-amino-propane 1 3-diols
ATE172711T1 (de) * 1992-10-21 1998-11-15 Yoshitomi Pharmaceutical 2-amino-1, 3- propandiolverbindung und immunosuppressium
DE69524962D1 (de) * 1994-08-22 2002-02-14 Welfide Corp Benzolderivate und deren medizinische verwendung

Also Published As

Publication number Publication date
IL155066A0 (en) 2003-10-31
ATE271028T1 (de) 2004-07-15
ES2226110T3 (es) 2005-03-16
JP4045364B2 (ja) 2008-02-13
PT1319651E (pt) 2005-09-30
EP1002792B1 (en) 2004-07-14
SI1002792T1 (en) 2004-12-31
AU6523098A (en) 1998-10-30
KR100551931B1 (ko) 2006-02-16
DK1319651T3 (da) 2005-08-01
DE69825056D1 (de) 2004-08-19
EP1319651B1 (en) 2005-06-29
IL132208A (en) 2003-07-31
EP1319651A3 (en) 2004-01-02
NZ500713A (en) 2000-07-28
DE69830756D1 (de) 2005-08-04
IL155065A (en) 2004-01-04
EP1319651A2 (en) 2003-06-18
AU735853B2 (en) 2001-07-19
SI1319651T1 (en) 2005-10-31
DE69830756T2 (de) 2006-05-04
EP1002792A1 (en) 2000-05-24
IL155066A (en) 2004-06-20
CN1290819C (zh) 2006-12-20
CN1259117A (zh) 2000-07-05
WO1998045249A1 (fr) 1998-10-15
DE69825056T2 (de) 2005-08-25
CN1480450A (zh) 2004-03-10
ES2240868T3 (es) 2005-10-16
EP1002792A4 (en) 2002-03-20
CA2286315A1 (en) 1998-10-15
RU2198162C2 (ru) 2003-02-10
USRE39072E1 (en) 2006-04-18
DK1002792T3 (da) 2004-11-22
IL155065A0 (en) 2003-10-31
CA2286315C (en) 2007-03-06
ATE298740T1 (de) 2005-07-15
CN1137086C (zh) 2004-02-04
IL132208A0 (en) 2001-03-19
BR9808481A (pt) 2000-05-23
US6214873B1 (en) 2001-04-10
KR20010006004A (ko) 2001-01-15

Similar Documents

Publication Publication Date Title
PT1002792E (pt) Compostos de 2-aminopropano-1,3-diol, sua utilizacao medicinal e intermediariosda sintese dos mesmos
ATE406893T1 (de) Pharmazeutische zusammensetzung (kit) enthaltend dihydropyridinonverbindungen und eine verbindung mit immunmodulatorischer (oder antiinflammatorischer) wirkung und ihre verwendung
CA2126337A1 (en) 2-amino-1,3-propanediol compound and immunosuppressant
ES2148254T3 (es) Peptidos antimicrobianos ciclicos y preparacion de los mismos.
FI862210A0 (fi) Imidazoheterocykliska foereningar och foerfarande foer deras framstaellning.
EP0780128A3 (de) Zubereitung, enthaltend Lipoproteine und Crotonsäureamidderivate
ES2096073T3 (es) Derivado de benzamida.
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
ATE267191T1 (de) Tricyclische aminderivate
DK0420121T3 (da) Antitumormiddel
ATE101138T1 (de) Parabansaeure-derivate und pharmazeutische zusammensetzungen damit.
EA199700287A1 (ru) Бензамиды для лечения нейродегенеративных заболеваний
DE69001004D1 (de) Zusammensetzung gegen leberkrankheiten.
ES2107799T3 (es) Compuestos de cefema de actividad antimicrobiana.
DE3585070D1 (de) Tetrahydro-1,2,4-oxadiazin-5-thion-derivate.
TH10148EX (th) ซับสทิทิวเทด คาร์บอกซิเททระไฮโดรไอโซควิโนลีนและอนุพันธ์พันธ์ของสารเหล่านั้นซึ่งมีความว่องไวทางเภสัชศาสตร์
TH14708A (th) นิวคลีโอไซด์ที่ใช้เป็นยารักษา
TH14708EX (th) นิวคลีโอไซด์ที่ใช้เป็นยารักษา